Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ShellfishGene
    Member
    • Mar 2009
    • 14

    Quality checking transcriptome assemblies

    Dear all,

    I am currently working on 454 transcriptome data. I have assembled the reads using the current newbler version, MIRA, and will try Velvet/Oases later on.
    However, I am still not sure how to decide on one assembly to use for all further analysis. Comparing the basic statistics like contig length, reads per contig, N50 and so on only gives hints to which may be the better assembly. From these stats I would have choosen the newbler assembly, but they do not really tell me how well the transcripts are assembled. Alternative splicing and gene copies can make for bad assemblies, for example.
    Some methods I thought of that may tell me more are looking at single genes that have a known sequence, and check how the transcripts for these genes are assembled. However, that has to be done manually, and is only possible for a few genes.
    Maybe one could also blast all contigs and check which assembly gives more or better hits, or how many hits one contig has on average. Too many hits per contig could maybe mean that multiple transcripts are assembled to one contig.

    How do you check assembly quality beyond the basic stats? Without a sequenced genome, of course.

    Cheers,

    Till
  • Xi Wang
    Senior Member
    • Oct 2009
    • 317

    #2
    It is mentioned by Oases that the transcriptome assembly is quite different from genome assembly, due to the alternative splicing and different gene expression levels. Therefore, the old statistics may not be applicable to transcriptome assembly.
    Xi Wang

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...